Quoin Pharmaceuticals Ltd QNRX

Healthcare Biotechnology

Quoin Pharmaceuticals Ltd, former Cellect Biotechnology Ltd, is an Israel-based specialty pharmaceutical company, focused on developing and commercializing therapeutic products that treat rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.

NDAQ:QNRX - Post by User

Quoin Pharmaceuticals Ltd

<< Previous

Bullboard Posts

Next >>

Post by Iseneschalon Jul 21, 2023 10:29am

64 Views

Post# 35551387

QNRX....You know there's a P.O in the making ; )

https://www.sec.gov/Archives/edgar/data/1671502/000110465923082042/tm2321541d1_424b3.htm

I'd say there will be a big push up in the share price and also a huge volume increase...JMHO

Wait for it.... Ya gotta churn it ....to earn it ...to burn it. Cheers !!

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market